Akin Tekin

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Transplants 56%
3. Transplantation 50%
4. Tissue Donors 27%
5. Pediatrics 25%
6. Liver 24%
7. Transplant Recipients 19%
8. Thrombosis 19%
9. Hepatic Artery 18%
10. Kidney Transplantation 15%
11. Alemtuzumab 15%
12. Portal Vein 14%
13. End Stage Liver Disease 13%
14. Graft Survival 12%
15. Immunosuppression 12%
16. Kidney 12%
17. Natural Killer Cells 11%
18. Survival 11%
19. Biopsy 10%
20. Hepatocellular Carcinoma 9%
21. Antibodies 8%
22. Uterus 8%
23. Citrulline 8%
24. Veins 8%
25. Liver Failure 7%
26. Graft Rejection 7%
27. Allografts 7%
28. Autologous Transplantation 7%
29. Hepatitis C 6%
30. Therapeutics 6%
31. Abdomen 6%
32. Wolcott-Rallison syndrome 6%
33. Acute Liver Failure 6%
34. Paraffin 5%
35. Liver Diseases 5%
36. Neoplasms 5%
37. Superior Mesenteric Artery 5%
38. Fibrosis 5%
39. Recurrence 5%
40. Coronavirus 5%
41. Mortality 5%
42. Portal Hypertension 5%
43. Mesentery 5%
44. Hepatoblastoma 5%
45. Immunosuppressive Agents 5%
46. Prune Belly Syndrome 5%
47. Intestines 5%